Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Epigenetics

• Publication date

  2018-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/15592294.2018.1460032PMID 29613828PMCID PMC6140820
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Faculty Opinions recommendation of Expert consensus document: Mitochondrial function as a therapeutic target in heart failure.

  2019cited by this paper
• Targeting mitochondrial dysfunction in the treatment of heart failure

  2016cited by this paper
• Mitochondrial function as a therapeutic target in heart failure

  2016cited by this paper
• Rapid mitochondrial dysfunction mediates TNF‐alpha‐induced neurotoxicity

  2015cited by this paper
• Histone Deacetylases Exert Class-Specific Roles in Conditioning the Brain and Heart Against Acute Ischemic Injury

  2015cited by this paper
• TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells.

  2015cited by this paper
• Histone deacetylases as therapeutic targets--from cancer to cardiac disease.

  2015cited by this paper
• Inflammatory cytokines as biomarkers in heart failure.

  2015cited by this paper
• Novel Histone Deacetylase Inhibitor Modulates Cardiac Peroxisome Proliferator-Activated Receptors and Inflammatory Cytokines in Heart Failure

  2015cited by this paper
• Mitochondria and NADPH oxidases are the major sources of TNF-α/cycloheximide-induced oxidative stress in murine intestinal epithelial MODE-K cells.

  2015cited by this paper
• Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation.

  2014cited by this paper
• Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

  2014cited by this paper
• Mitochondrial dysfunction in heart failure

  2013cited by this paper
• Epigenetic regulation of canonical TNFα pathway by HDAC1 determines survival of cardiac myocytes.

  2013cited by this paper
• Imbalance between HAT and HDAC Activities in the PBMCs of Patients with Ankylosing Spondylitis or Rheumatoid Arthritis and Influence of HDAC Inhibitors on TNF Alpha Production

  2013cited by this paper
• Inhibition of Class I Histone Deacetylases Unveils a Mitochondrial Signature and Enhances Oxidative Metabolism in Skeletal Muscle and Adipose Tissue

  2013influential reference
• Mitochondria in heart failure: the emerging role of mitochondrial dynamics

  2013cited by this paper
• Heart failure: the pivotal role of histone deacetylases.

  2013cited by this paper
• Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure.

  2013cited by this paper
• Mitochondria as a therapeutic target in heart failure.

  2013cited by this paper
• Therapeutic potential for HDAC inhibitors in the heart.

  2012cited by this paper
• Targeting Inflammation in Heart Failure with Histone Deacetylase Inhibitors

  2011cited by this paper
• Function of histone deacetylase inhibitors in inflammation.

  2011cited by this paper
• Succinate Dehydrogenase Is a Direct Target of Sirtuin 3 Deacetylase Activity

  2011cited by this paper
• Tumor necrosis factor-&agr; decreases sarcoplasmic reticulum Ca2+-ATPase expressions via the promoter methylation in cardiomyocytes*

  2010cited by this paper
• Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-alpha in synovial tissue of rheumatoid arthritis

  2010cited by this paper
• Mitochondrial respiratory complex I: structure, function and implication in human diseases.

  2009cited by this paper
• TNF-induced mitochondrial damage: a link between mitochondrial complex I activity and left ventricular dysfunction.

  2009cited by this paper
• New aspects of impaired mitochondrial function in heart failure

  2009cited by this paper
• Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.

  2008cited by this paper
• Lysine acetylation: codified crosstalk with other posttranslational modifications.

  2008cited by this paper
• Tumor Necrosis Factor-&agr; and Mortality in Heart Failure: A Community Study

  2008cited by this paper
• Inhibition of tumor necrosis factor-alpha-inducible inflammatory genes by interferon-gamma is associated with altered nuclear factor-kappaB transactivation and enhanced histone deacetylase activity.

  2007cited by this paper
• Histone Deacetylase 3 Interacts with and Deacetylates Myocyte Enhancer Factor 2

  2006cited by this paper
• Tumour necrosis factor-alpha depletes histone deacetylase 1 protein through IKK2.

  2006cited by this paper
• Tumour necrosis factor‐α depletes histone deacetylase 1 protein through IKK2

  2006cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle

  2003cited by this paper
• Structural biasing elements for in-cell histone deacetylase paralog selectivity.

  2003cited by this paper
• An autoregulatory loop controls peroxisome proliferator-activated receptor gamma coactivator 1alpha expression in muscle.

  2003cited by this paper
• Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1

  2003cited by this paper
• Attenuation of a phosphorylation-dependent activator by an HDAC–PP1 complex

  2003cited by this paper
• Abnormal mitochondrial respiration in failed human myocardium.

  2000cited by this paper
• The role of tumor necrosis factor in the pathophysiology of heart failure.

  2000cited by this paper
• Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats.

  1998cited by this paper
• Expression and functional significance of tumor necrosis factor receptors in human myocardium.

  1995cited by this paper
• Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man.

  1992cited by this paper

• The interplay of epigenetic remodelling and transposon-mediated genomic instability in ageing and longevity.

  2026cites this paper
• Histone deacetylases in myocardial infarction: Orchestrating programmed cell death pathways and emerging therapeutic opportunities.

  2025cites this paper
• Cardiac and Digestive Forms of Chagas Disease: An Update on Pathogenesis, Genetics, and Therapeutic Targets

  2025cites this paper
• Enhanced Mitochondrial Dynamics and Reactive Oxygen Species Levels with Reduced Antioxidant Defenses in Human Epicardial Adipose Tissue

  2025cites this paper
• Role of Histone Deacetylase and Inhibitors in Cardiovascular Diseases

  2025cites this paper
• Ketogenic diet and β-hydroxybutyrate inhibit HDAC1 to preserve vascular smooth muscle cell function in thoracic aortic aneurysm

  2025cites this paper
• Unlocking cardiac health: exploring the role of class I HDACs in cardiovascular diseases

  2025cites this paper
• Lithium downregulates phosphorylated acetyl‑CoA carboxylase 2 and attenuates mitochondrial fatty acid utilization and oxidative stress in cardiomyocytes

  2024cites this paper
• YAP1 preserves tubular mitochondrial quality control to mitigate diabetic kidney disease

  2024cites this paper
• Genetic deletion or pharmacologic inhibition of HDAC6 protects the heart against ischemia/reperfusion injury by limiting TNFα-induced mitochondrial injury in experimental diabetes.

  2024cites this paper
• Class I and II Histone Deacetylase Inhibitors as Therapeutic Modulators of Dilated Cardiac Tissue-Derived Mesenchymal Stem/Stromal Cells

  2024cites this paper
• Male histone deacetylase 6 (HDAC6) knockout mice have enhanced ventilatory responses to hypoxic challenge

  2024cites this paper
• Expanding the Frontiers of Guardian Antioxidant Selenoproteins in Cardiovascular Pathophysiology

  2024cites this paper
• Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19

  2023cites this paper
• Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy

  2023cites this paper
• Urolithin A protects severe acute pancreatitis‐associated acute cardiac injury by regulating mitochondrial fatty acid oxidative metabolism in cardiomyocytes

  2023cites this paper
• Cardiomyocyte-targeting exosomes from sulforaphane-treated fibroblasts affords cardioprotection in infarcted rats

  2023cites this paper
• Gut microbiota and cardiac arrhythmia

  2023cites this paper
• Augmentation of Histone Deacetylase 6 Activity Impairs Mitochondrial Respiratory Complex I in Ischemic/Reperfused Diabetic Hearts

  2023cites this paper
• The role of histone deacetylase 3 in breast cancer

  2022cites this paper
• Standpoints in Mitochondrial Dysfunction: Underlying Mechanisms in Search of Therapeutic Strategies.

  2022cites this paper
• Short communication: TNF-α and IGF-1 regulates epigenetic mechanisms of HDAC2 and HDAC10

  2022influential citation
• Role of succinate dehydrogenase in hepatocellular carcinoma

  2022cites this paper
• Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions

  2022cites this paper
• Histone Deacetylase 3: A Potential Therapeutic Target for Atherosclerosis

  2022cites this paper
• Differential molecular mechanistic behavior of HDACs in cancer progression

  2022cites this paper
• HDAC3 impairs cardiac function in chronic heart failure rats via mediating microRNA-26b-3p to target high mobility group AT-hook 2.

  2022cites this paper
• Therapeutic potential of HDAC inhibitors in the treatment of cardiac diseases: A short review.

  2022cites this paper
• Class I HDAC modulates angiotensin II–induced fibroblast migration and mitochondrial overactivity

  2021cites this paper
• Mitochondrial Arrest on the Microtubule Highway—A Feature of Heart Failure and Diabetic Cardiomyopathy?

  2021cites this paper
• Prediction of single-cell mechanisms for disease progression in hypertrophic remodelling by a trans-omics approach

  2021cites this paper
• Knock-Down of HDAC2 in Human Induced Pluripotent Stem Cell Derived Neurons Improves Neuronal Mitochondrial Dynamics, Neuronal Maturation and Reduces Amyloid Beta Peptides

  2021cites this paper
• Acute Kidney Injury Results in Long-Term Diastolic Dysfunction That Is Prevented by Histone Deacetylase Inhibition

  2021cites this paper
• Reduction of HDAC2 expression in human induced pluripotent stem cell derived neurons improves neuronal maturation, mitochondrial dynamics and cellular neurodegenerative disease phenotypes

  2021cites this paper
• The Protective Role of Bmal1-Regulated Autophagy Mediated by HDAC3/SIRT1 Pathway in Myocardial Ischemia/Reperfusion Injury of Diabetic Rats

  2021cites this paper
• Histone Deacetylase 2 (HDAC2) influences maturation and mitochondrial dynamics in human induced pluripotent stem cell derived neurons

  2021cites this paper
• Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis

  2021cites this paper
• Exercise improves cardiac function and glucose metabolism in mice with experimental myocardial infarction through inhibiting HDAC4 and upregulating GLUT1 expression

  2020cites this paper
• Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.

  2020cites this paper
• Sodium Butyrate-Modulated Mitochondrial Function in High-Insulin Induced HepG2 Cell Dysfunction

  2020cites this paper
• Investigating Ass1 and its role in renal fibrosis

  2020cites this paper
• Output Regulation and Function Optimization of Mitochondria in Eukaryotes

  2020cites this paper
• Gene Expression Profiling of Multiple Histone Deacetylases (HDAC) and Its Correlation with NRF2-Mediated Redox Regulation in the Pathogenesis of Diabetic Foot Ulcers

  2020cites this paper
• Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.

  2020cites this paper
• Pathological Responses of Cardiac Mitochondria to Burn Trauma

  2020cites this paper
• Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis

  2019cites this paper
• Genetic, epigenetic and biochemical regulation of succinate dehydrogenase function

  2019cites this paper
• Modulation of mitochondrial dysfunction for treatment of disease.

  2019cites this paper
• Novel molecular therapeutic targets in cardiac fibrosis: a brief overview 1.

  2019cites this paper
• Sodium hydrosulphide restores tumour necrosis factor‐α‐induced mitochondrial dysfunction and metabolic dysregulation in HL‐1 cells

  2019cites this paper
• Reduction of HDAC2 expression in human induced pluripotent stem cell derived neurons improves neuronal

  year unknowncites this paper